Amsterdam's Ellogon secures €1M to advance personalised immunotherapy innovation : vimarsana.com

Amsterdam-based Ellogon, a company working on personalising immunotherapy with data and algorithms, announced that it has secured €1M in fresh funding from

Related Keywords

Amsterdam , Noord Holland , Netherlands , North Holland , Dutch , Robert Kuipers , Janet Nieboer , Transition Fund , University Of Amsterdam , Uva Ventures Holding , Netherlands Cancer Institute , University Of Amsterdam Uv , Uva Ventures , Ventures Holding ,